These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Rickard AJ; Morgan J; Tesch G; Funder JW; Fuller PJ; Young MJ Hypertension; 2009 Sep; 54(3):537-43. PubMed ID: 19635989 [TBL] [Abstract][Full Text] [Related]
7. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis. Bienvenu LA; Morgan J; Rickard AJ; Tesch GH; Cranston GA; Fletcher EK; Delbridge LM; Young MJ Endocrinology; 2012 Jul; 153(7):3416-25. PubMed ID: 22653557 [TBL] [Abstract][Full Text] [Related]
8. Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Rickard AJ; Morgan J; Chrissobolis S; Miller AA; Sobey CG; Young MJ Hypertension; 2014 May; 63(5):1033-40. PubMed ID: 24566081 [TBL] [Abstract][Full Text] [Related]
9. Deoxycorticosterone/Salt-Mediated Cardiac Inflammation and Fibrosis Are Dependent on Functional CLOCK Signaling in Male Mice. Fletcher EK; Morgan J; Kennaway DR; Bienvenu LA; Rickard AJ; Delbridge LMD; Fuller PJ; Clyne CD; Young MJ Endocrinology; 2017 Sep; 158(9):2906-2917. PubMed ID: 28911177 [TBL] [Abstract][Full Text] [Related]
10. Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease. Parker BM; Wertz SL; Pollard CM; Desimine VL; Maning J; McCrink KA; Lymperopoulos A Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486399 [TBL] [Abstract][Full Text] [Related]
11. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis. Rickard AJ; Funder JW; Fuller PJ; Young MJ Endocrinology; 2006 Dec; 147(12):5901-6. PubMed ID: 16990342 [TBL] [Abstract][Full Text] [Related]
12. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes. Tsai CF; Yang SF; Chu HJ; Ueng KC Int J Cardiol; 2013 Oct; 169(1):17-28. PubMed ID: 24120080 [TBL] [Abstract][Full Text] [Related]
13. Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart. Wilson P; Morgan J; Funder JW; Fuller PJ; Young MJ Clin Sci (Lond); 2009 May; 116(9):731-9. PubMed ID: 18990085 [TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models. Lieber GB; Fernandez X; Mingo GG; Jia Y; Caniga M; Gil MA; Keshwani S; Woodhouse JD; Cicmil M; Moy LY; Kelly N; Jimenez J; Crawley Y; Anthes JC; Klappenbach J; Ma YL; McLeod RL Eur J Pharmacol; 2013 Oct; 718(1-3):290-8. PubMed ID: 24012780 [TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways. Sun JY; Li C; Shen ZX; Zhang WC; Ai TJ; Du LJ; Zhang YY; Yao GF; Liu Y; Sun S; Naray-Fejes-Toth A; Fejes-Toth G; Peng Y; Chen M; Liu X; Tao J; Zhou B; Yu Y; Guo F; Du J; Duan SZ Arterioscler Thromb Vasc Biol; 2016 May; 36(5):874-85. PubMed ID: 26966277 [TBL] [Abstract][Full Text] [Related]
16. The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature. Belden Z; Deiuliis JA; Dobre M; Rajagopalan S Am J Nephrol; 2017; 46(4):298-314. PubMed ID: 29017166 [TBL] [Abstract][Full Text] [Related]
17. Deoxycorticosterone Acetate/Salt-Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure. Lother A; Fürst D; Bergemann S; Gilsbach R; Grahammer F; Huber TB; Hilgendorf I; Bode C; Moser M; Hein L Hypertension; 2016 Jan; 67(1):130-8. PubMed ID: 26553231 [TBL] [Abstract][Full Text] [Related]
18. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats. Yasuoka S; Kai H; Kajimoto H; Kudo H; Takayama N; Anegawa T; Koga M; Miyamoto T; Mifune H; Kage M; Hirooka Y; Imaizumi T Circ J; 2013; 77(6):1474-81. PubMed ID: 23470864 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Young MJ Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):174-80. PubMed ID: 18277151 [TBL] [Abstract][Full Text] [Related]
20. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration? Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]